Last reviewed · How we verify
NCT06933901: OPU-CLBR
Impact of the Operator Performing Oocyte Retrieval on the Cumulative Live Birth Rate
trial testing Oocyte retrieval in Infertility (IVF Patients) in 19,500 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | Istituto Clinico Humanitas |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 19,500 |
| Start date | 1 January 2013 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
Drugs / interventions tested
- Oocyte retrieval
Conditions studied
- Infertility (IVF Patients) — all drugs for Infertility (IVF Patients) →
- Oocyte Retrieval — all drugs for Oocyte Retrieval →
Sponsor
Istituto Clinico Humanitas
Who can join
Eligibility, any sex, with Infertility (IVF Patients) or Oocyte Retrieval. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a monocentric retrospective observational study. The study investigates the impact of the operator performing the oocyte retrieval on the cumulative live birth rate (CLBR). The objectives of the study are as follows: * To evaluate whether the operator performing the oocyte retrieval influences the probability of pregnancy, expressed as the cumulative live birth rate (CLBR). * To assess whether operator performance improves with increased experience. To address the study objectives, data will be collected using a specific internal web-based database. All oocyte retrieval procedures performed at the Humanitas Fertility Center from January 2013 to December 2022 will be included in the evaluation. Outcomes will be expressed in terms of CLBR.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06933901
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oocyte retrieval
Trials testing the same drug.
- NCT03458143 — Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval · unknown
- NCT05895227 — Hemorrhagic Complications of Transvaginal Oocyte's Retrieval: an Update. · completed
Other recruiting trials for Infertility (IVF Patients)
Currently open trials in the same condition.
- NCT07185724 — Ketorolac Use and Fresh Embryo Transfer Outcomes · Phase 4 · recruiting
- NCT07323329 — Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization · Phase 2, PHASE3 · recruiting
- NCT07148999 — An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera · Phase 1, PHASE2 · recruiting
- NCT07004192 — The Role of hCG in Thawed Embryo Transfer · Phase 4 · recruiting
- NCT06717802 — Endometrial Receptivity Prediction During in Vitro Fertilization Using Artificial Intelligence · recruiting
Other Istituto Clinico Humanitas trials
Trials by the same sponsor.
- NCT06944288 — Microbiota as Early Diagnostic and predictivE Factor for Osteoarthritic Degeneration and Microbial Contamination · NA · not yet recruiting
- NCT07358247 — Postoperative Outcomes of Single-stapled Anastomosis Combined With Transanal Natural Orifice Specimen Extraction · not yet recruiting
- NCT07362342 — RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery · not yet recruiting
- NCT07346274 — Intra-operative Hypotension and Post-operative Lactate Level After Pancreatic-duodenectomy. · enrolling by invitation
- NCT07491419 — The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06933901 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Clinico Humanitas
- Last refreshed: 25 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06933901.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing